CVS HEALTH Corp reported revenue of $106.10B for the period ended 2026-06-30, +7.3% year on year. Net income was $2.98B, a 2.8% net margin on a 44.5% gross margin. Free cash flow for the period was $5.65B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $106.10B | +7.3% |
| Gross profit | $47.23B | — |
| Operating income | $4.70B | — |
| Net income | $2.98B | +191.8% |
| Gross margin | 44.5% | Net margin 2.8% |
| Revenue Q/Q | +5.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $58.86B | 55.5% |
| Tax & other | $1.72B | 1.6% |
| Item | Amount |
|---|---|
| Total assets | $253.77B |
| Total liabilities | $173.87B |
| Shareholders' equity | $79.90B |
| Equity / assets | 31.5% |
| Operating cash flow | $6.34B |
| Capital expenditure | $0.69B |
| Free cash flow | $5.65B |
| Cash conversion (OCF / net income) | 213% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
DHR ・ DRI ・ DDOG ・ DVA ・ DECK ・ DE ・ DELL ・ DAL ・ DVN ・ DXCM ・ FANG ・ DLR
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies